Cadonilimab and Lenvatinib
1 clinical trials · Condition
◉ Watch Cadonilimab and Lenvatinib
| Record | Firm | Date |
|---|---|---|
| Cadonilimab and Lenvatinib for Conversion Therapy in Unresectable Hepatocellular Carcinoma (NCT06215651) | Peking Union Medical College Hospital | 2024-03-11 |
Track Cadonilimab and Lenvatinib automatically
Every clearance here is in the API, with alerts when new ones post.